View in EDS

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.

Saved in:
Bibliographic Details
Title: Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.
Authors: Simonsen CS; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway., Flemmen HØ; Department of Neurology, Hospital Telemark HF, Skien, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Broch L; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway., Brekke K; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Neurology, Hospital Vestfold, Tønsberg, Norway., Brunborg C; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway., Berg-Hansen P; Department of Neurology, Oslo University Hospital, Oslo, Norway., Celius EG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.
Source: Frontiers in neurology [Front Neurol] 2022 Nov 14; Vol. 13, pp. 1034056. Date of Electronic Publication: 2022 Nov 14 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36452173
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Simonsen+CS%22">Simonsen CS</searchLink>; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.<br /><searchLink fieldCode="AU" term="%22Flemmen+HØ%22">Flemmen HØ</searchLink>; Department of Neurology, Hospital Telemark HF, Skien, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Broch+L%22">Broch L</searchLink>; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Brekke+K%22">Brekke K</searchLink>; Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Neurology, Hospital Vestfold, Tønsberg, Norway.<br /><searchLink fieldCode="AU" term="%22Brunborg+C%22">Brunborg C</searchLink>; Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Berg-Hansen+P%22">Berg-Hansen P</searchLink>; Department of Neurology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Celius+EG%22">Celius EG</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Neurology, Oslo University Hospital, Oslo, Norway.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101546899%22">Frontiers in neurology</searchLink> [Front Neurol] 2022 Nov 14; Vol. 13, pp. 1034056. <i>Date of Electronic Publication: </i>2022 Nov 14 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101546899 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2295 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642295%22">16642295 </searchLink><i>NLM ISO Abbreviation: </i>Front Neurol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36452173
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fneur.2022.1034056
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1034056
    Titles:
      – TitleFull: Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Simonsen CS
      – PersonEntity:
          Name:
            NameFull: Flemmen HØ
      – PersonEntity:
          Name:
            NameFull: Broch L
      – PersonEntity:
          Name:
            NameFull: Brekke K
      – PersonEntity:
          Name:
            NameFull: Brunborg C
      – PersonEntity:
          Name:
            NameFull: Berg-Hansen P
      – PersonEntity:
          Name:
            NameFull: Celius EG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 11
              Text: 2022 Nov 14
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1664-2295
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in neurology
              Type: main
ResultId 1